TUESDAY, Jan. 6, 2026 (HealthDay News) — A daily pill for weight loss has officially arrived in the U.S. On Monday, Novo ...

Danish obesity drugmaker Novo Nordisk's head of public affairs in the U.S. has left the company, according to an internal ...

Novo Nordisk’s Wegovy weight-loss pill is now broadly available across the U.S., two weeks after it received U.S. regulatory ...

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering doses of 1.5 ...

Pharmaceutical company Novo Nordisk announced that a new pill-version of its GLP-1 weight-loss drug is now "broadly available ...

FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo ...

TORONTO — Novo Nordisk Canada is considering competing with generic versions of its brand-name Ozempic and Wegovy drugs by ...

Vault CRM is part of the Vault CRM Suite of deep applications and agentic AI that drive more effective commercial execution ...

Shares of Novo Nordisk rose about 1.5% on early Wednesday after its International Operations unit committed to using Veeva ...

Wegovy pill introduction in the U.S. may serve as the turning point that transforms a beleaguered GLP‑1 leader into a viable ...

Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...